IQVIA Holdings Inc - Asset Resilience Ratio

Latest as of June 2026: 0.57%

IQVIA Holdings Inc (IQV) has an Asset Resilience Ratio of 0.57% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of IQVIA Holdings Inc to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$171.00 Million
Cash + Short-term Investments

Total Assets

$29.88 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how IQVIA Holdings Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of IQVIA Holdings Inc.

Liquid Assets Composition Over Time

This chart breaks down IQVIA Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore IQVIA Holdings Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $171.00 Million 0.57%
Total Liquid Assets $171.00 Million 0.57%

Asset Resilience Insights

  • Limited Liquidity: IQVIA Holdings Inc maintains only 0.57% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

IQVIA Holdings Inc Industry Peers by Asset Resilience Ratio

Compare IQVIA Holdings Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Healius Ltd
AU:HLS
Diagnostics & Research 0.06%
Prodia Widyahusada Tbk PT
JK:PRDA
Diagnostics & Research 7.82%
RHYTHM Biosciences Ltd
AU:RHY
Diagnostics & Research 2.74%
Check Cap Ltd
NASDAQ:CHEK
Diagnostics & Research 70.29%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%

Annual Asset Resilience Ratio for IQVIA Holdings Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for IQVIA Holdings Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 7.15% $2.14 Billion $29.94 Billion +0.30pp
2024-12-31 6.85% $1.84 Billion $26.90 Billion +1.24pp
2023-12-31 5.61% $1.50 Billion $26.68 Billion +0.44pp
2022-12-31 5.17% $1.31 Billion $25.34 Billion -0.82pp
2021-12-31 5.98% $1.48 Billion $24.69 Billion -1.76pp
2020-12-31 7.74% $1.90 Billion $24.56 Billion +3.88pp
2019-12-31 3.87% $899.00 Million $23.25 Billion -0.29pp
2018-12-31 4.16% $938.00 Million $22.55 Billion -0.26pp
2017-12-31 4.42% $1.00 Billion $22.74 Billion -1.42pp
2016-12-31 5.84% $1.24 Billion $21.21 Billion +6.68pp
2015-12-31 -0.84% $-32.91 Million $3.93 Billion +0.21pp
2014-12-31 -1.04% $-34.50 Million $3.31 Billion +0.27pp
2013-12-31 -1.32% $-40.35 Million $3.07 Billion +0.12pp
2012-12-31 -1.44% $-35.95 Million $2.50 Billion -0.49pp
2011-12-31 -0.95% $-22.11 Million $2.32 Billion --
pp = percentage points

About IQVIA Holdings Inc

NYSE:IQV USA Diagnostics & Research
Market Cap
$44.46 Billion
Market Cap Rank
#707 Global
#333 in USA
Share Price
$270.09
Change (1 day)
+0.08%
52-Week Range
$156.66 - $271.62
All Time High
$282.61
About

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more